Evidence map›Paper›PMID 42064076›Full record

ArticleFrontiers in immunology2026

Thalidomide-mediated immunomodulation in a patient with

Aiyan Ren, Qian Zeng, Bin Zhang, Xue Chuan, Yalin Wu, Meiting Wang, Huan Ren, Yan Chen, Pei Huang, Zuochen Du

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aiyan RenDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Qian ZengDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Bin ZhangDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Xue ChuanDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Yalin WuDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Meiting WangDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Huan RenDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Yan ChenDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Pei HuangDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Zuochen DuDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Very early-onset inflammatory bowel disease (VEO-IBD) is frequently triggered by monogenic defects in the pathways responsible for immune system regulation, including mutations in the interleukin-10 receptor alpha ( Methods: A female patient aged 2 months diagnosed with VEO-IBD was enrolled in the study. Clinical data were gathered over time. Whole-exome sequencing was utilized to uncover pathogenic variants for genomic analysis. The expression of Results: The patient experienced chronic diarrhea, failure to thrive, and recurrent infections. Genetic analysis revealed the presence of compound heterozygous mutations in the Discussion: This study confirms the immune dysregulation caused by

Indexed as

ImmunomodulationInflammatory Bowel DiseasesInterleukin-10 Receptor alpha SubunitThalidomideFemaleHumansInfantMutationInterleukin-10 Receptor alpha SubunitThalidomideIL-10RAinflammatory bowel diseasemutationthalidomideT lymphocytes

Identifiers

PMID42064076
PMCPMC13125077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.